Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain | 11 | 2013 | 290 | 2.020 |
Why?
|
| Estradiol | 6 | 2016 | 268 | 1.560 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 5 | 2014 | 39 | 1.510 |
Why?
|
| Sex Characteristics | 7 | 2010 | 258 | 1.310 |
Why?
|
| Receptors, Opioid | 7 | 2013 | 40 | 1.230 |
Why?
|
| Estrogens | 7 | 2009 | 203 | 1.200 |
Why?
|
| Opioid Peptides | 6 | 2009 | 26 | 1.180 |
Why?
|
| Nociceptors | 9 | 2006 | 30 | 1.170 |
Why?
|
| Pain Measurement | 9 | 2016 | 183 | 1.110 |
Why?
|
| Analgesics | 5 | 2016 | 55 | 1.050 |
Why?
|
| N-Methylaspartate | 11 | 2009 | 59 | 1.040 |
Why?
|
| Rats, Sprague-Dawley | 23 | 2016 | 1766 | 0.880 |
Why?
|
| Trigeminal Caudal Nucleus | 5 | 2006 | 6 | 0.870 |
Why?
|
| Testosterone | 4 | 2010 | 211 | 0.850 |
Why?
|
| Receptors, Opioid, mu | 4 | 2016 | 52 | 0.840 |
Why?
|
| Receptors, Opioid, kappa | 2 | 2016 | 23 | 0.830 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 98 | 0.800 |
Why?
|
| Neurons | 9 | 2003 | 1263 | 0.760 |
Why?
|
| Clonidine | 6 | 2014 | 50 | 0.760 |
Why?
|
| Rats | 23 | 2016 | 3735 | 0.730 |
Why?
|
| Ovariectomy | 9 | 2016 | 127 | 0.700 |
Why?
|
| Receptors, Estrogen | 2 | 2013 | 183 | 0.550 |
Why?
|
| Spinal Cord | 4 | 2016 | 114 | 0.530 |
Why?
|
| Pentazocine | 1 | 2016 | 4 | 0.500 |
Why?
|
| Trigeminal Nuclei | 3 | 2009 | 11 | 0.500 |
Why?
|
| Estrogen Antagonists | 1 | 2016 | 30 | 0.490 |
Why?
|
| Trigeminal Nerve | 3 | 2000 | 32 | 0.440 |
Why?
|
| Adrenergic alpha-Agonists | 5 | 2008 | 32 | 0.430 |
Why?
|
| Serum Albumin, Bovine | 1 | 2014 | 49 | 0.410 |
Why?
|
| Hot Temperature | 6 | 2016 | 141 | 0.410 |
Why?
|
| Medulla Oblongata | 5 | 2000 | 42 | 0.400 |
Why?
|
| Excitatory Amino Acid Agonists | 4 | 2002 | 43 | 0.400 |
Why?
|
| Animals | 24 | 2016 | 16992 | 0.400 |
Why?
|
| Receptors, Opioid, delta | 3 | 1996 | 23 | 0.380 |
Why?
|
| Pain Threshold | 4 | 2016 | 34 | 0.350 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2014 | 1124 | 0.340 |
Why?
|
| Adrenergic alpha-Antagonists | 5 | 2009 | 29 | 0.340 |
Why?
|
| Analgesia | 1 | 2010 | 11 | 0.340 |
Why?
|
| Receptors, Adrenergic, alpha | 2 | 2002 | 17 | 0.340 |
Why?
|
| Estrous Cycle | 4 | 2016 | 37 | 0.300 |
Why?
|
| Hyperalgesia | 1 | 2009 | 24 | 0.300 |
Why?
|
| Trigeminal Nucleus, Spinal | 2 | 2002 | 4 | 0.290 |
Why?
|
| Naloxone | 7 | 2000 | 56 | 0.290 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 72 | 0.280 |
Why?
|
| Excitatory Amino Acids | 2 | 1999 | 7 | 0.280 |
Why?
|
| Male | 21 | 2013 | 23409 | 0.270 |
Why?
|
| Drug Interactions | 4 | 2014 | 150 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 386 | 0.240 |
Why?
|
| Analgesics, Opioid | 2 | 2000 | 252 | 0.240 |
Why?
|
| Orchiectomy | 3 | 2010 | 37 | 0.220 |
Why?
|
| Pons | 1 | 2004 | 11 | 0.220 |
Why?
|
| Signal Transduction | 1 | 2014 | 2157 | 0.220 |
Why?
|
| Female | 12 | 2016 | 24698 | 0.220 |
Why?
|
| Injections, Spinal | 2 | 2016 | 8 | 0.210 |
Why?
|
| Reaction Time | 3 | 2014 | 157 | 0.210 |
Why?
|
| Yohimbine | 3 | 2009 | 24 | 0.200 |
Why?
|
| Substance P | 2 | 2004 | 26 | 0.200 |
Why?
|
| Narcotic Antagonists | 5 | 2006 | 78 | 0.200 |
Why?
|
| Evoked Potentials | 3 | 1998 | 91 | 0.200 |
Why?
|
| Morphine | 2 | 1993 | 69 | 0.190 |
Why?
|
| Oligopeptides | 2 | 2000 | 109 | 0.180 |
Why?
|
| Time Factors | 3 | 2014 | 1857 | 0.180 |
Why?
|
| Somatosensory Cortex | 2 | 1999 | 26 | 0.180 |
Why?
|
| Area Under Curve | 2 | 2010 | 95 | 0.150 |
Why?
|
| Behavior, Animal | 3 | 2008 | 373 | 0.140 |
Why?
|
| Analysis of Variance | 2 | 2010 | 575 | 0.140 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 4 | 2000 | 13 | 0.140 |
Why?
|
| Thalamus | 1 | 1996 | 34 | 0.120 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 2 | 2010 | 4 | 0.120 |
Why?
|
| Naltrexone | 2 | 2010 | 34 | 0.110 |
Why?
|
| Physical Stimulation | 3 | 2000 | 27 | 0.100 |
Why?
|
| Sex Factors | 2 | 2008 | 1028 | 0.100 |
Why?
|
| Neurons, Afferent | 1 | 1993 | 44 | 0.100 |
Why?
|
| Cold Temperature | 1 | 1993 | 40 | 0.100 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 3 | 1996 | 6 | 0.090 |
Why?
|
| Cattle | 1 | 2014 | 498 | 0.090 |
Why?
|
| Enkephalins | 3 | 1996 | 31 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 458 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 883 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2013 | 403 | 0.090 |
Why?
|
| Lumbosacral Region | 1 | 2010 | 14 | 0.080 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2010 | 14 | 0.080 |
Why?
|
| Testosterone Propionate | 1 | 2009 | 3 | 0.080 |
Why?
|
| Iontophoresis | 2 | 2000 | 10 | 0.080 |
Why?
|
| Catheterization | 1 | 2009 | 22 | 0.080 |
Why?
|
| Hormone Replacement Therapy | 1 | 2009 | 49 | 0.080 |
Why?
|
| Mustard Plant | 1 | 2009 | 7 | 0.080 |
Why?
|
| Irritants | 1 | 2009 | 8 | 0.080 |
Why?
|
| Plant Oils | 1 | 2009 | 20 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 652 | 0.070 |
Why?
|
| Arrestin | 1 | 2008 | 8 | 0.070 |
Why?
|
| Castration | 1 | 2008 | 34 | 0.070 |
Why?
|
| Catecholamines | 1 | 2006 | 45 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 149 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2008 | 1035 | 0.060 |
Why?
|
| Inflammation | 1 | 2010 | 758 | 0.060 |
Why?
|
| Dioxanes | 1 | 2004 | 11 | 0.060 |
Why?
|
| Estrogen Receptor beta | 1 | 2003 | 39 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 41 | 0.050 |
Why?
|
| Microinjections | 1 | 2002 | 50 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2003 | 121 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2002 | 139 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2000 | 186 | 0.040 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1999 | 10 | 0.040 |
Why?
|
| Action Potentials | 1 | 2001 | 246 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 1999 | 59 | 0.040 |
Why?
|
| Idazoxan | 1 | 1998 | 10 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1271 | 0.030 |
Why?
|
| Mice | 1 | 2008 | 6644 | 0.030 |
Why?
|
| Benzylidene Compounds | 1 | 1996 | 6 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 1996 | 37 | 0.030 |
Why?
|
| Microelectrodes | 1 | 1996 | 22 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1996 | 135 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 1992 | 169 | 0.020 |
Why?
|